Kelly Blackburn
Fortune : 42 389 $ au 30/06/2026
Fortune : 42 389 $ au 30/06/2026
Kelly Blackburn currently works at Bach Pharma, Inc., as Chief Executive Officer & Director from 2016 and CervoMed, Inc., as Executive Vice President-Clinical Development from 2025.
Ms. Blackburn also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Clinical & Safety Operations from 2002 to 2006, aTyr Pharma, Inc., as Vice President-Clinical Affairs from 2013 to 2016, Vertex Pharmaceuticals, Inc., as Vice President-Clinical Development Operations from 2006 to 2012, and EIP Pharma, Inc., as Senior Vice President-Clinical Development from 2018 to 2023.
Ms. Blackburn received her undergraduate degree from the University of New Hampshire, graduate degree from Quinnipiac College, Inc., and graduate degree from Cambridge College Lima SRL.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERVOMED INC. 0,1% | 17/04/2026 | 13 674 ( 0,1% ) | 42 389 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CERVOMED INC. | Directeur Technique/Scientifique/R&D | 16/08/2023 |
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 15/07/2016 |
| Sociétés | Poste | Fin |
|---|---|---|
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Corporate Officer/Principal | 01/08/2023 |
| ATYR PHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/07/2016 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/09/2012 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/08/2006 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quinnipiac College, Inc.
Quinnipiac College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge College Lima SRL
Cambridge College Lima SRL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
CervoMed, Inc.
CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national